Skip to content

Clinical trials

Phase 2 Urinary Bladder Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 2 Country / region: Italy Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20051
20061
20071
20091
20103
20112
20121
20144
20161
20171
20183
20193
20202
20211
20223
20232
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting6
Terminated5
Unknown status4
Active, not recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano6
European Organisation for Research and Treatment of Cancer - EORTC3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Bristol-Myers Squibb2
Merck Sharp & Dohme LLC2
A.O.U. Città della Salute e della Scienza1
Achieve Life Sciences1
Astellas Pharma Inc1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms40
Carcinoma, Transitional Cell11
Non-Muscle Invasive Bladder Neoplasms4
Ovarian Neoplasms4
Urethral Neoplasms4
Breast Neoplasms3
Cholangiocarcinoma3
Endometrial Neoplasms3
Esophageal Neoplasms3
Pancreatic Neoplasms3

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.